House Committee Blocks CMS AI-Powered Prior Authorization Pilot

The House Appropriations Committee has voted to block the Centers for Medicare & Medicaid Services (CMS) from funding a controversial AI-powered prior authorization pilot program. Known as the Wasteful and Inappropriate Services Reduction (WISeR) model, this initiative aimed to streamline the prior authorization process in traditional Medicare by leveraging artificial intelligence. However, it faced significant opposition from both healthcare providers and lawmakers, leading to a unanimous vote to prevent its implementation.

The amendment, added to the broader appropriations bill for the Department of Health and Human Services (HHS), explicitly states that "none of the funds made available in this Act or any other Act" should be used to implement WISeR or any similar model that would introduce prior authorization requirements to traditional Medicare. This decision comes as part of the 2027 appropriations bill, which was initially unveiled on June 4 and will undergo further congressional review before final passage.

The Controversy Surrounding WISeR

The WISeR model was introduced in June 2025 with the goal of reducing fraud, waste, and abuse within Medicare. It proposed a streamlined prior authorization process that would use AI to automate certain aspects of the approval system. However, the program quickly drew criticism from various quarters.

Provider organizations such as the American Hospital Association (AHA) and the American Medical Association (AMA) were among the first to voice their concerns. They argued that the model could create significant burdens and delays for both patients and healthcare providers. The AHA and AMA have long advocated for reducing administrative overhead and improving patient access to care, and they see WISeR as a step in the wrong direction.

In May, Democratic lawmakers introduced a bill that would overturn the WISeR program using the Congressional Review Act (CRA). This act allows Congress to review and potentially nullify federal agency rules. The legislators contend that CMS should have submitted the model for congressional review before implementing it, ensuring transparency and accountability in the process.

Why It Matters

The decision by the House Appropriations Committee underscores a growing debate over the role of AI in healthcare policy. While proponents argue that AI can enhance efficiency and reduce costs, critics raise concerns about patient privacy, provider autonomy, and the potential for unintended consequences.

AI is becoming increasingly prevalent in healthcare, but not all AI tools are created equal. The absence of clear regulatory guidelines for generative AI poses challenges in ensuring their ethical and responsible use. As payers face rising pressures to manage costs, the need for robust oversight and evaluation of AI-driven models becomes even more critical.

The committee's amendment highlights the importance of congressional oversight in such initiatives. It emphasizes that any proposal to impose prior authorization requirements on traditional Medicare should be subject to thorough review and transparent evaluation of its impacts on beneficiary access to care and provider burden. This move is a clear signal that policymakers are taking a cautious approach to integrating AI into healthcare systems, prioritizing the well-being of patients and providers over rapid technological adoption.

The next steps for WISeR and similar programs will likely involve further legislative scrutiny and public debate. As healthcare continues to evolve, the balance between innovation and regulation will remain a key focus for policymakers and stakeholders alike.